Teva���s U.S. Generic-Drug Sales Tumbled on Manufacturing Problem

3 billion. The stock sells for 8.8 times estimated profit, making it the second-cheapest of 10 global drug companies of similar size. Only AstraZeneca Plc is cheaper. ���The perception of Teva changed massively over the past year, from a company which...